These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6055230)

  • 21. Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood.
    Battista MC; Oligny LL; St-Louis J; Brochu M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E124-31. PubMed ID: 12067852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired differential renal function in a child with pheochromocytoma.
    Chotsampancharoen T; Patrapinyokul S; Reegkling C; Vachvanichsanong P
    J Hum Hypertens; 2005 Sep; 19(9):751-4. PubMed ID: 15931236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension in different types of nephropathies (review of 633 cases)].
    Rodicio Díaz JL; Egido de los Rios J; Casado Pérez S; Hernando Avendaño L
    Rev Clin Esp; 1974 May; 133(4):331-8. PubMed ID: 4409746
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypertension and changes in renal function].
    Chanard J
    Rev Prat; 1993 Dec; 43(20 Suppl):22-6. PubMed ID: 8146579
    [No Abstract]   [Full Text] [Related]  

  • 25. [Certain mechanisms of change in vasomotor function in normal animals and in the initial stage of development of experimental hypertension under the effect of sunlight and ultraviolet rays].
    Baronenko VA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1968; 33(4):331-7. PubMed ID: 5736801
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biological markers of renal dysfunction in essential arterial hypertension in African subjects].
    Djoumessi S; Nouedoui C; Youmbissi TJ; Essengue Behl GF
    Ann Biol Clin (Paris); 2000; 58(5):615-7. PubMed ID: 11022107
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-inflammatory agents and renal function.
    Brater DC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function, sodium excretion and the renin-angiotensin-aldosterone system in relation to blood pressure. An epidemiological and physiological study.
    Ljungman S
    Acta Med Scand Suppl; 1982; 663():108. PubMed ID: 6983814
    [No Abstract]   [Full Text] [Related]  

  • 29. Ace inhibition in renal disease: risks and benefits.
    Campanacci L; Fabris B; Fischetti F; Bardelli M; Vran F; Carretta R
    Clin Exp Hypertens; 1993; 15 Suppl 1():173-86. PubMed ID: 8513308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of angiotensin I converting enzyme inhibitors on renal function indicators in hypertensive patients].
    Sedlak-Vadoc V; Ubavić M; Stosić Z; Curić S
    Med Pregl; 1993; 46(3-4):87-91. PubMed ID: 7862050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the effect of caffeine on the peripheral circulation and its neural regulation].
    Buhr G
    Arztl Forsch; 1966 Feb; 20(2):89-94. PubMed ID: 6013800
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute protein loading in the assessment of renal reserve.
    Loo CS; Zaki M; Sulaiman AB; Sukanya AB; Voon YC; Kua SL
    Med J Malaysia; 1994 Mar; 49(1):36-43. PubMed ID: 8057988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on N-acetyl-beta-glucosaminidase (NAG) activities in the urine. II. The relation between NAG activities and various renal function tests in renal diseases].
    Uno E; Sano K
    Rinsho Byori; 1984 Apr; 32(4):419-24. PubMed ID: 6471495
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isotope nephrography with the use of vasoactive drugs].
    Löbe J; Hackel F; Gursky S
    Radiol Diagn (Berl); 1965; 6(3):329-34. PubMed ID: 5839118
    [No Abstract]   [Full Text] [Related]  

  • 35. The kallikrein-kinin system, renal function and hypertensive diseases.
    Margolius HS
    Prog Biochem Pharmacol; 1980; 17():116-22. PubMed ID: 6908057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasomotor escape from noradrenaline in the renal, mesenteric and hindquarter vascular beds in spontaneously hypertensive rats (SHR).
    Wróblewski TE; Grójec M
    Acta Physiol Pol; 1984; 35(4):324-9. PubMed ID: 6545926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal response to prostaglandin E1 infusion in polycystic kidney disease versus non-polycystic renal disease.
    Uemasu J; Munemura C; Fujihara M; Kawasaki H
    Clin Nephrol; 1995 Oct; 44(4):225-30. PubMed ID: 8575121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 39. [Para-aminohippuric acid clearance test: (with special reference to RPF and FF)].
    Yokomatsu M; Ohno J
    Rinsho Byori; 1982 Mar; Suppl 49():52-6. PubMed ID: 7109249
    [No Abstract]   [Full Text] [Related]  

  • 40. [Association of urotensin II and diabetes mellitus and kidney diseases].
    Pei HC; Li MZ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):1003-5. PubMed ID: 16061011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.